Advertisement
For patients with breast cancer

Goserelin Protects Against Ovarian Failure in Breast Cancer

0
Randomized trial shows reduction in ovarian failure and more pregnancy for chemo + goserelin
A mobile phone application has been released to identify current drug shortages

FDA Launches First App to Identify Drug Shortages

0
App IDs shortages, resolved shortages, product discontinuation; can be used to report shortages
For patients with atrial fibrillation receiving anticoagulant treatment

Anemia Linked to Adverse Outcomes in Atrial Fibrillation

0
Increased risk of thromboembolic events, bleeding complications, mortality during anticoagulant tx
For patients with advanced-stage esophageal squamous cell carcinoma

HPV-16 Tied to Improved Survival in Advanced Esophageal Cancer

0
Improved survival and treatment response for HPV-16 positive patients
Rush University Medical Center's website has started adding the results of patient surveys to individual physician profiles

Rush University Adds Patient Scores to Doctor Profiles

0
Scores based on 30 or more patient surveys completed in one-year period
Use of localized correlated spectroscopy shows significant changes in women with BRCA1 and BRCA2 mutations

Correlated Spectroscopy IDs Changes in BRCA1/2 Carriers

0
Lipid and metabolite deregulation seen in breast tissue of women carrying BRCA1/2 mutations
U.S. Food and Drug Administration approval of Opdivo (nivolumab) has been expanded to include advanced non-small-cell lung cancer

FDA: Opdivo Approval Expanded to Include Lung Cancer

0
FDA approves drug for NSCLC patients who have been treated with platinum-based chemotherapy
Patients prefer physicians who convey a more optimistic message

Research Measures Perceptions of Physician Compassion

0
Patients perceive higher level of compassion among physicians who provide a more optimistic message

February 2015 Briefing – Hematology & Oncology

0
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for February 2015. This roundup includes...
For patients with non-small-cell lung cancer with epidermal growth factor receptor mutations

L858R Mutation in Circulating Free DNA Is Prognostic in NSCLC

0
L858R mutation in tumor tissue or cfDNA is marker of shorter overall, progression-free survival